Clinical Trials Directory

Trials / Completed

CompletedNCT01586065

Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes

Use of CGM in Adolescents With Poorly-controlled Type 1 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Nemours Children's Clinic · Academic / Other
Sex
All
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to see if children and adolescents with poorly controlled type 1 diabetes will benefit from using a continuous glucose monitor (CGM), a device that can be used to check blood sugars.

Detailed description

Adolescents with type 1 diabetes, HbA1c ≥9% on insulin pumps were admitted to the clinical research center and a continuous glucose sensor was inserted. Sensor glucose (SG) values were compared to plasma glucose measured at least hourly using Yellow Springs Instrument's (YSI) glucose analyzer. SG rather than YSI was used for treatment decisions unless YSI was \<70 mg/dL or specific criteria indicating SG and YSI were very discordant were met.

Conditions

Interventions

TypeNameDescription
DEVICEContinuous Glucose Monitor (CGM)CGM during 24-hr CRC stay.

Timeline

Start date
2012-02-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2012-04-26
Last updated
2023-06-28
Results posted
2023-06-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01586065. Inclusion in this directory is not an endorsement.